ERNA - CIK 0000748592
Eterna Therapeutics Inc. has filed 1,000 documents with the SEC between 2010 and 2026. The most frequent type is insider trade (317 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-20 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G | - | 2026-05-14 | - |
| SCHEDULE 13G | - | 2026-05-14 | - |
| SCHEDULE 13G/A | - | 2026-05-13 | - |
| Annual report to shareholders | ARS | 2026-05-11 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-05-11 | - |
| Proxy statement | DEF 14A | 2026-05-11 | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-11 | 2026-03-31 |
| Major company event | 8-K | 2026-05-04 | 2026-05-01 |
| DEF 14C | - | 2026-04-13 | 2026-04-13 |
| PRE 14C | - | 2026-04-01 | 2026-04-01 |
| EFFECT | - | 2026-03-30 | - |
| Company correspondence | CORRESP | 2026-03-26 | - |
| S-3/A | - | 2026-03-24 | - |
| Major company event | 8-K | 2026-03-20 | 2026-03-18 |
| SEC correspondence | UPLOAD | 2026-03-20 | - |
| Securities registration | S-3 | 2026-03-16 | - |
| Annual report | 10-K | 2026-03-13 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| SCHEDULE 13D/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-17 | 2026-02-10 |
| Major company event | 8-K | 2026-02-11 | 2026-02-06 |
| Prospectus supplement | 424B5 | 2026-02-10 | - |
| EFFECT | - | 2026-02-05 | - |
| 8-A12B | - | 2026-02-05 | - |
| S-1/A | - | 2026-02-05 | - |
| Exchange certification | CERT | 2026-02-05 | - |
| S-1/A | - | 2026-02-04 | - |
| IPO registration | S-1 | 2026-02-03 | - |
| SCHEDULE 13G/A | - | 2025-12-19 | - |
| SCHEDULE 13G/A | - | 2025-12-16 | - |
| Major company event | 8-K | 2025-12-11 | 2025-12-11 |
| Quarterly report | 10-Q | 2025-11-07 | 2025-09-30 |
| DRS | - | 2025-10-23 | - |
| SCHEDULE 13G/A | - | 2025-08-18 | - |
| Quarterly report | 10-Q | 2025-08-13 | 2025-06-30 |
| Insider trade | 4 | 2025-07-07 | 2025-06-21 |
| Major company event | 8-K | 2025-07-07 | 2025-06-30 |
| EFFECT | - | 2025-06-18 | - |
| 424B3 | - | 2025-06-18 | - |
| Company correspondence | CORRESP | 2025-06-16 | - |
| SEC correspondence | UPLOAD | 2025-06-16 | - |
| Major company event | 8-K | 2025-06-12 | 2025-06-12 |
| Employee stock plan | S-8 | 2025-06-11 | - |
| Securities registration | S-3 | 2025-06-11 | - |
| SCHEDULE 13D/A | - | 2025-06-11 | - |
| Insider trade | 4 | 2025-06-11 | 2025-06-09 |
| Major company event | 8-K | 2025-06-09 | 2025-06-09 |